CLSI C43-A2 PDF

CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.

This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.